Boekholdt, S M <br/><br/>
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.  [electronic resource] 

 -  Circulation  Jan 2005 
 - 278-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.CIR.0000153341.46271.40  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Diseases--epidemiology<br/>Carrier Proteins--genetics<br/>Cholesterol Ester Transfer Proteins<br/>Cholesterol, HDL--blood<br/>Glycoproteins--genetics<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Polymorphism, Genetic<br/>Pravastatin--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Regression Analysis<br/>Risk<br/>Taq Polymerase